If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Trading Update

10 Jan 2006 07:00

Embargoed Release: 07:00hrs Tuesday 10th January 2006 SOPHEON PLC ("Sopheon") TRADING UPDATE Sopheon plc, the international provider of solutions that improve the returnfrom innovation and product development, announces that revenues for the secondhalf of 2005 are expected to be 40% higher than the ‚£1.9m reported for thefirst six months of the year. We closed 18 license transactions includingextension orders in the period, taking the total number of licensed customersto 70. Revenue growth in the US was particularly strong with turnover 60%higher than in the first half of the year. The revenue increase is expected toreduce the group's EBITDA losses for the second half of 2005 to under a thirdof the ‚£0.8m reported for the first six months. This expectation would havebeen for a breakeven second half, but for additional subcontractor costsincurred to deliver on services business which continued to run ahead ofhistoric trends.The above performance does not fully reflect the strength of our underlyingcommercial progress. In addition to the business closed last year, we have inhand conditional contracts and commitments that represent overall salespotential of the order of ‚£2m, of which approximately half could come throughin the shorter term. Originally targeted for completion in 2005, this business,together with other opportunities under negotiation, provides a strong positionto start the new year. In addition, our annual maintenance base coming into2006 has grown to over ‚£1.3m.Sopheon's strategic partnership with Microsoft is producing tangible businessimpact, with three Accolade license sales aided by support from Microsoft'ssales team. Seven new active business opportunities are a direct result ofjoint marketing at Microsoft events and such marketing activity will continuein 2006. Later this month, for example, Sopheon will be among a select group ofpartners that will be featured at the Microsoft Office Project 2006 Conferencefor end-users and partners in Seattle. During the period we also received freshmarket affirmation from IDC, a global IT research and advisory firm, whichcredited Sopheon with first-mover status for our actions to capitalize on theconvergence of the product life cycle management and portfolio managementmarkets.On the corporate front, Sopheon recently completed the full conversion of itsconvertible loan note, and renewed the group's ¢â€š¬10m equity line facility withGEM Global Yield Fund through December 2007.Financial expectations noted above are subject to the completion of theyear-end financial close process. Consistent with prior years, Sopheon plans toissue its 2005 preliminary results in early April. This will be brought forwarddepending on the speed with which the conversion to International FinancialReporting Standards is completed.Sopheon's Chairman, Barry Mence said:"While achieving 40% growth compared to the first half of the year is aconsiderable improvement, we are disappointed that continued sensitivity to thetiming of individual deals prevented us from exceeding even this performance,and that we were not able to achieve market expectations for earnings.Nevertheless, the extent of commercial activity in which we are engagedunderpins our continued confidence in the direction of our business. We look tofurther cement our leading position in our target markets as we move towardsthe important milestone of 100 licensed customers."For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010About SopheonSopheon (LSE:SPE) is an international provider of software and services thathelp organizations improve the business impact of product development. TheSopheon Accolade‚® product development system automates gate- or phase-basedproduct development (PD) processes and provides strategic decision support thatallows companies to improve innovation, cut product development spending wasteand shorten time to market. Sopheon is listed on the AIM market of the LondonStock Exchange and on the Euronext in the Netherlands. For more information,please visit www.sopheon.com.ENDSOPHEON PLC
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.